Results 151 to 160 of about 12,653 (257)

Public health preparedness in times of regional crisis: lessons from Cyprus and the Eastern Mediterranean. [PDF]

Eur J Public Health
Heraclides A, Middleton N, Tsantidou M, Panayiotou AG, Kolokotroni O, Achilleos S, Lamnisos D, Tolma EL, McKee M.   +8 more
europepmc   +1 more source

Graphene Materials for Sustainable Energy Applications: A Contemporary Perspective

Carbon Energy, EarlyView.
ABSTRACT Graphene has garnered significant attention as a promising material with great potential for contributing to sustainable energy initiatives, such as RE100 (100% renewable energy initiative) and CF100 (100% carbon‐free initiative). This review aims to explore the potential of graphene for advancing renewable energy applications by highlighting
Niraj Kumar, Seul‐Yi Lee, Roop L. Mahajan, Soo‐Jin Park   +3 more
wiley   +1 more source

Patterns in Marine Fungal Diversity and Community Structure on Native Versus Invasive Macroalgae at a Local Geographic Scale. [PDF]

Microb Ecol
Owen EAM, Griffiths RI, Golyshin PN, Chernikova TN, Kurr M.   +4 more
europepmc   +1 more source

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

ChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

Registries and surveillance models used to screen neonates for congenital anomalies in LMIC settings: a scoping review. [PDF]

BMJ Public Health
Nawab M, Arain HA, Sherwani M, Aronsen K, Channar A, Angell Bolkan H, R Ames HM, Samad L.   +7 more
europepmc   +1 more source

Navigating the Prescription Drug Information System

Clinical Pharmacology &Therapeutics, EarlyView.
Information on new prescription drugs is increasingly complex and fragmented, posing challenges for healthcare professionals, patients, and payers. Clinicians require concise, actionable guidance to support prescribing decisions, while patients seek to balance benefits and harms when making decisions aligned with their treatment goals.
Irina V. Wang, Courtney Davis, Robin Forrest, Avi Cherla, Maximilian Siebert, Janice Cowden, Sophia Walker, Tamar Krishnamurti, Florence T. Bourgeois, Steven Woloshin, Anita K. Wagner, Huseyin Naci   +11 more
wiley   +1 more source

Quality of life in breast cancer survivors: insights from a university hospital in Sri Lanka. [PDF]

BMC Cancer
Perera R, Wijethunga D, Perera M, Abeywickrama C, Lakshman MP, Gunawardana H, Herath P.   +6 more
europepmc   +1 more source

Fecal Microbiota Transplantation and Microbiota‐Based Therapeutics in Allogeneic Hematopoietic Stem Cell Transplantation: Current Evidence and Future Directions

Clinical Pharmacology &Therapeutics, EarlyView.
The intestinal microbiome is a key regulator of immune homeostasis, metabolism, and epithelial barrier integrity. In patients with malignant hematological diseases, particularly those undergoing hematopoietic stem cell transplantation, microbiome perturbations by reduced diversity, pathobiont expansion, and loss of beneficial metabolites are common as ...
Bálint Gergely Szabó, Dorina Korózs, Michal Bator, Krisztina Jeszenszky, Viktor Lakatos, László Gopcsa, Péter Reményi, János Sinkó   +7 more
wiley   +1 more source

A dataset of smart home devices sold on Spanish e-commerce platforms. [PDF]

Data Brief
Quintana-Vera J, González-Tablas AI, Rashed M.   +2 more
europepmc   +1 more source

When ESG Becomes Value: Stock Market Rewards of Sustainable Banking in Europe

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study examines the relationship between sustainable investing and stock performance in the European banking sector. Specifically, it investigates the impact of the overall ESG score as well as the individual ESG pillars on stock performance, with particular attention to differences across high‐capital‐buffer and large‐sized banks.
Antoine B. Awad
wiley   +1 more source